Health Trials

Patients With Primary HPV High-grade Squamous Intra-epithelial Lesions (HSIL) at Cervical Site

1

Review clinical trials related to Patients With Primary HPV High-grade Squamous Intra-epithelial Lesions (HSIL) at Cervical Site. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Trial to Evaluate Nonavalent HPV Vaccine as a Secondary Prevention in Patients Treated for Human Papilloma Virus Related High-grade Squamous Intraepithelial Lesions

Randomized, placebo-controlled phase 3 trial to evaluate nonavalent HPV vaccine as a secondary prevention in patients treated for human papilloma virus related high-grade squamous intraepithelial lesions.

Participants needed: 984
Trial details
Phase: Phase 3Age: 18-55Biological sex: AllType: InterventionalSponsor: Gustave Roussy, Cancer Campus, Grand ParisUpdated: Feb 27, 2026
Eligibility criteria

Women, men, transgender,18 ≤age ≤55 [+8]

History of HPV related cancer (i.e. anal, genital, head and neck, cutaneous, pen... [+9]

Read more